Fulton Bank N.A. Sells 750 Shares of Aetna Inc. (AET)
Fulton Bank N.A. reduced its stake in Aetna Inc. (NYSE:AET) by 3.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,006 shares of the company’s stock after selling 750 shares during the period. Fulton Bank N.A.’s holdings in Aetna were worth $3,181,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Guardian Life Insurance Co. of America increased its holdings in Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after purchasing an additional 9 shares in the last quarter. Financial Architects Inc increased its holdings in Aetna by 1.8% in the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock valued at $265,000 after purchasing an additional 31 shares in the last quarter. Wedbush Securities Inc. increased its holdings in Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock valued at $574,000 after purchasing an additional 52 shares in the last quarter. Calamos Wealth Management LLC increased its holdings in Aetna by 0.7% in the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock valued at $1,354,000 after purchasing an additional 65 shares in the last quarter. Finally, HM Payson & Co. increased its holdings in Aetna by 0.5% in the 1st quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock valued at $1,641,000 after purchasing an additional 69 shares in the last quarter. Hedge funds and other institutional investors own 89.52% of the company’s stock.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.
Aetna Inc. (AET) traded up 1.28% during midday trading on Wednesday, reaching $157.90. 880,629 shares of the company traded hands. The firm’s 50 day moving average price is $158.29 and its 200 day moving average price is $149.19. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $164.52. The firm has a market capitalization of $52.44 billion, a price-to-earnings ratio of 35.05 and a beta of 0.53.
Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. During the same period in the previous year, the business earned $2.21 EPS. The firm’s revenue was down 2.7% on a year-over-year basis. On average, analysts expect that Aetna Inc. will post $9.56 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.28%. Aetna’s dividend payout ratio (DPR) is currently 43.67%.
Several analysts recently issued reports on AET shares. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a report on Tuesday, July 4th. Citigroup Inc. assumed coverage on shares of Aetna in a research report on Wednesday, June 28th. They issued a “buy” rating and a $180.00 price objective for the company. BidaskClub cut shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Argus reissued a “buy” rating and issued a $185.00 price objective (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Finally, Deutsche Bank AG upped their price objective on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a research report on Thursday, July 13th. Nine research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus price target of $161.83.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.